‌

US Patent 8846030 Compounds and methods to enhance rAAV transduction

Patent 8846030 was granted and assigned to University of Iowa on September, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

University of Iowa

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

88460300

Patent Inventor Names

Dongsheng Duan0

John F. Engelhardt0

Date of Patent

September 30, 2014

Patent Application Number

113016010

Date Filed

December 13, 2005

Patent Citations Received

‌

US Patent 12123002 Compositions and methods of treating amyotrophic lateral sclerosis (ALS)

‌

US Patent 11951121 Compositions and methods for treating Huntington's disease

‌

US Patent 11999965 None

‌

US Patent 12071625 Modulatory polynucleotides

‌

US Patent 12084659 Modulatory polynucleotides

‌

US Patent 12116589 Treatment of amyotrophic lateral sclerosis (ALS)

‌

US Patent 11684679 AAV-mediated expression using a synthetic promoter and enhancer

‌

US Patent 11697825 Compositions and methods for the production of scAAV

...

Patent Primary Examiner

‌

Maria Marvich

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8846030 Compounds and methods to enhance rAAV transduction

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API